← Mechanisms of action
Voltage-gated potassium channel
PROTEIN FAMILYHomo sapiens
Linked proteins
- Potassium voltage-gated channel subfamily KQT member 1 (KCNQ1) ↗
- Potassium voltage-gated channel subfamily D member 3 (KCND3) ↗
- Potassium voltage-gated channel subfamily H member 2 (KCNH2) ↗
- Potassium voltage-gated channel subfamily A member 2 (KCNA2) ↗
- Potassium voltage-gated channel subfamily A member 1 (KCNA1) ↗
- Potassium voltage-gated channel subfamily KQT member 2 (KCNQ2) ↗
- Potassium voltage-gated channel subfamily KQT member 3 (KCNQ3) ↗
- Potassium voltage-gated channel subfamily A member 7 (KCNA7) ↗
- Potassium voltage-gated channel subfamily KQT member 5 (KCNQ5) ↗
- Potassium voltage-gated channel subfamily KQT member 4 (KCNQ4) ↗
- Potassium voltage-gated channel subfamily H member 1 (KCNH1) ↗
- Potassium voltage-gated channel subfamily A member 4 (KCNA4) ↗
- Potassium voltage-gated channel subfamily A member 5 (KCNA5) ↗
- Potassium voltage-gated channel subfamily A member 3 (KCNA3) ↗
- Potassium voltage-gated channel subfamily A member 6 (KCNA6) ↗
- Potassium voltage-gated channel subfamily C member 1 (KCNC1) ↗
- Potassium voltage-gated channel subfamily D member 2 (KCND2) ↗
- Potassium voltage-gated channel subfamily B member 2 (KCNB2) ↗
- Potassium voltage-gated channel subfamily C member 4 (KCNC4) ↗
- Potassium voltage-gated channel subfamily C member 3 (KCNC3) ↗
- Potassium voltage-gated channel subfamily B member 1 (KCNB1) ↗
- Potassium voltage-gated channel subfamily A member 10 (KCNA10) ↗
- Potassium voltage-gated channel subfamily V member 1 (KCNV1) ↗
- Potassium voltage-gated channel subfamily H member 5 (KCNH5) ↗
- Potassium voltage-gated channel subfamily G member 3 (KCNG3) ↗
- Potassium voltage-gated channel subfamily G member 4 (KCNG4) ↗
- Potassium voltage-gated channel subfamily V member 2 (KCNV2) ↗
- Potassium voltage-gated channel subfamily S member 1 (KCNS1) ↗
- Potassium voltage-gated channel subfamily H member 8 (KCNH8) ↗
- Potassium voltage-gated channel subfamily C member 2 (KCNC2) ↗
- Potassium voltage-gated channel subfamily S member 3 (KCNS3) ↗
- Potassium voltage-gated channel subfamily H member 6 (KCNH6) ↗
- Potassium voltage-gated channel subfamily F member 1 (KCNF1) ↗
- Potassium voltage-gated channel subfamily H member 7 (KCNH7) ↗
- Potassium voltage-gated channel subfamily D member 1 (KCND1) ↗
- Potassium voltage-gated channel subfamily G member 1 (KCNG1) ↗
- Potassium voltage-gated channel subfamily G member 2 (KCNG2) ↗
- Potassium voltage-gated channel subfamily H member 3 (KCNH3) ↗
- Potassium voltage-gated channel subfamily S member 2 (KCNS2) ↗
- Potassium voltage-gated channel subfamily H member 4 (KCNH4) ↗
Drugs acting on this target (6)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| amifampridine phosphate (firdapse) | Antagonist | approved | Small molecule | Voltage-gated potassium channel antagonist |
| amifampridine phosphate (firdapse) | Blocker | approved | Small molecule | Voltage-gated potassium channel blocker |
| dalfampridine (ampyra) | Blocker | approved | Small molecule | Voltage-gated potassium channel blocker |
| guanidine | Blocker | approved | Small molecule | Voltage-gated potassium channel blocker |
| nerispirdine | Blocker | experimental | Small molecule | Voltage-gated potassium channel blocker |
| tedisamil sesquifumarate | Blocker | experimental | Small molecule | Voltage-gated potassium channel blocker |